Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05221645
Title Pembrolizumab in Combination With R-ICE Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (P+R-ICE)
Acronym P+R-ICE
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Southampton
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR

Facility Status City State Zip Country Details
Oxford Cancer & Haematology Centre, The Churchill Hospital RECRUITING Headington Oxford OX3 7LE United Kingdom Details
The Beatson West of Scotland Cancer Centre RECRUITING Glasgow G12 0YN United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field